Literature DB >> 28347231

Animal models as a tool in hepatocellular carcinoma research: A Review.

Nuno Paula Santos1,2, Aura Antunes Colaço1, Paula Alexandra Oliveira1,2.   

Abstract

Cancer is the first cause of death in developed countries and the second in developing countries. Concerning the most frequent worldwide-diagnosed cancer, primary liver cancer represents approximately 4% of all new cancer cases diagnosed globally. However, among primary liver cancer, hepatocellular carcinoma is by far the most common histological subtype. Notwithstanding the health promotion and disease prevention campaigns, more than half a million new hepatocellular carcinoma cases are reported yearly, being estimated to growth continuously until 2020. Taking this scenario under consideration and the fact that some aspects concerning hepatocellular carcinoma evolution and metastasize process are still unknown, animal models assume a crucial role to understand this disease. The animal models have also provided the opportunity to screen new therapeutic strategies. The present review was supported on research and review papers aiming the complexity and often neglected chemically induced animal models in hepatocarcinogenesis research. Despite the ongoing debate, chemically induced animal models, namely, mice and rat, can provide unique valuable information on the biotransformation mechanisms against xenobiotics and apprehend the deleterious effects on DNA and cell proteins leading to carcinogenic development. In addition, taking under consideration that no model achieves all hepatocellular carcinoma research purposes, criteria to define the " ideal" animal model, depending on the researchers' approach, are also discussed in this review.

Entities:  

Keywords:  Chemical carcinogens; genetically engineered mouse; liver; orthotopic; rodents; syngeneic; xenograft

Mesh:

Year:  2017        PMID: 28347231     DOI: 10.1177/1010428317695923

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  31 in total

1.  Acoustically Driven Microbubbles Enable Targeted Delivery of microRNA-Loaded Nanoparticles to Spontaneous Hepatocellular Neoplasia in Canines.

Authors:  Sukumar Uday Kumar; Arsenii V Telichko; Huaijun Wang; Dongwoon Hyun; Eric G Johnson; Michael S Kent; Robert B Rebhun; Jeremy J Dahl; William T N Culp; Ramasamy Paulmurugan
Journal:  Adv Ther (Weinh)       Date:  2020-11-12

2.  Lgr5+ pericentral hepatocytes are self-maintained in normal liver regeneration and susceptible to hepatocarcinogenesis.

Authors:  Chow Hiang Ang; Shih Han Hsu; Fusheng Guo; Chong Teik Tan; Victor C Yu; Jane E Visvader; Pierce K H Chow; Nai Yang Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-05       Impact factor: 11.205

3.  Pharmacokinetic herb-drug interactions between Aidi injection and doxorubicin in rats with diethylnitrosamine-induced hepatocellular carcinoma.

Authors:  Yuan Lu; Jie Pan; Xiaoqing Zhu; Shuai Zhang; Chunhua Liu; Jia Sun; Yueting Li; Siying Chen; Jing Huang; Chuang Cao; Yonglin Wang; Yongjun Li; Ting Liu
Journal:  BMC Pharmacol Toxicol       Date:  2021-09-06       Impact factor: 2.483

4.  Effects of Wnt-1 blockade in DEN-induced hepatocellular adenomas of mice.

Authors:  Argyrios Sklavos; Theofilos Poutahidis; Alexander Giakoustidis; Kali Makedou; Katerina Angelopoulou; Alexander Hardas; Paola Andreani; Argyro Zacharioudaki; George Saridis; Thomas Goulopoulos; Kalliopi Tsarea; Maria Karamperi; Vassilios Papadopoulos; Vassilios Papanikolaou; Apostolos Papalois; Stavros Iliadis; Satvinder Mudan; Daniel Azoulay; Dimitrios Giakoustidis
Journal:  Oncol Lett       Date:  2017-11-15       Impact factor: 2.967

5.  Integrative genomic analysis of mouse and human hepatocellular carcinoma.

Authors:  Michelle Dow; Rachel M Pyke; Brian Y Tsui; Ludmil B Alexandrov; Hayato Nakagawa; Koji Taniguchi; Ekihiro Seki; Olivier Harismendy; Shabnam Shalapour; Michael Karin; Hannah Carter; Joan Font-Burgada
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-04       Impact factor: 11.205

6.  Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.

Authors:  Hiroto Nishino; Hannah M Hollandsworth; Norihiko Sugisawa; Jun Yamamoto; Yoshihiko Tashiro; Sachiko Inubushi; Kazuyuki Hamada; Y U Sun; Hyein Lim; Siamak Amirfakhri; Filemoni Filemoni; Robert M Hoffman; Michael Bouvet
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  GSTM1 and GSTT1 copy number variants and the risk to Thai females of hepatocellular carcinoma.

Authors:  Thanet Sophonnithiprasert; Pensri Saelee; Tanett Pongtheerat
Journal:  J Gastrointest Oncol       Date:  2019-04

8.  New Approach about the Signaling Crosstalk between IQGAPs/ NF- κB/IL-8 and PDCD5/p53/TRAIL Pathways that Modulate Malignant Transformation in Hepatocellular Carcinoma.

Authors:  Khairy M A Zoheir; Mohamed A Abdelhafez; Ahmed M Darwish; Karima F Mahrous
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

9.  Molecular characterization of the grape seeds extract's effect against chemically induced liver cancer: In vivo and in vitro analyses.

Authors:  Alaaeldin Ahmed Hamza; Gehan Hussein Heeba; Hanan Mohamed Elwy; Chandraprabha Murali; Raafat El-Awady; Amr Amin
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

10.  Targeting hepatocarcinogenesis model in C56BL6 mice with pan-aurora kinase inhibitor Danusertib.

Authors:  Paschalis Gavriilidis; Theofilos Poutahidis; Alexander Giakoustidis; Kali Makedou; Katerina Angelopoulou; Alexander Hardas; Paola Andreani; Argyro Zacharioudaki; George Saridis; Athanasios Gargavanis; Eleni Louri; Nikolaos Antoniadis; Eleftheria Karampela; Nikolaos Psychalakis; Antonios Michalopoulos; Apostolos Papalois; Stavros Iliadis; Satvinder Mudan; Daniel Azoulay; Dimitrios Giakoustidis
Journal:  J Cancer       Date:  2018-02-27       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.